MARC Record from marc_columbia

LEADER: 05256fam a2200421 a 4500
001 4061024
005 20221027025952.0
008 981103t20002000paua b 001 0 eng c
010 $a 98050608
020 $a0721682995
035 $a(OCoLC)40311563
035 $a(OCoLC)ocm40311563
035 $9APQ6524HS
035 $a(NNC)4061024
035 $a4061024
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M$dOrLoB-B
050 00 $aRM301$b.K44 2000
060 10 $aQV 4$bK26p 2000
082 00 $a615.5/8$221
100 1 $aKee, Joyce LeFever.$0http://id.loc.gov/authorities/names/n82010933
245 10 $aPharmacology :$ba nursing process approach /$cJoyce LeFever Kee, Evelyn R. Hayes.
250 $a3rd ed.
260 $aPhiladelphia :$bSaunders,$c[2000], ©2000.
300 $axviii, 1032 pages :$billustrations (some color) ;$c28 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gUnit I.$tA Nurse's Perspective of Pharmacology.$g1.$tDrug Action: Pharmaceutic, Pharmacokinetic, and Pharmacodynamic Phases.$g2.$tNursing Process and Client Teaching.$g3.$tPrinciples of Drug Administration.$g4.$tMedication and Calculations --$gUnit II.$tContemporary Issues in Pharmacology.$g5.$tThe Drug Approval Process (U.S. and Canadian), Resources, and Ethical Considerations.$g6.$tTranscultural Considerations /$rLarry D. Purnell and Helene S. DeHaan.$g7.$tDrug Interaction, Over-the-Counter Drugs, and Drug Abuse.$g8.$tHerbal Therapy with Nursing Implications.$g9.$tDrug Therapy Considerations Throughout the Life Span.$g10.$tMedication Administration in Community Settings.$g11.$tThe Role of the Nurse in Drug Research --$gUnit III.$tNutrition and Electrolytes.$g12.$tVitamin and Mineral Replacement.$g13.$tFluid and Electrolyte Replacement.$g14.$tNutritional Support --$gUnit IV.$tNeurologic and Neuromuscular Agents.$g15.$tCentral Nervous System Stimulants.
505 80 $g16.$tCentral Nervous System Depressants: Sedative-Hypnotics and Anesthetics.$g17.$tNonnarcotic and Narcotic Analgesics.$g18.$tAnticonvulsants.$g19.$tAntipsychotics, Anxiolytics, and Antidepressants.$g20.$tAutonomic Nervous System.$g21.$tAdrenergics and Adrenergic Blockers.$g22.$tCholinergics and Anticholinergics.$g23.$tDrugs for Neuromuscular Disorders: Parkinsonism, Myasthenia Gravis, Multiple Sclerosis, Alzheimer's Disease, and Muscle Spasms --$gUnit V.$tAntiinflammatory and Antiinfective Agents.$g24.$tAntiinflammatory Drugs.$g25.$tAntibacterials: Penicillins and Cephalosporins.$g26.$tAntibacterials: Macrolides, Tetracyclines, Aminoglycosides, Fluoroquinolones.$g27.$tAntibacterials: Sulfonamides.$g28.$tAntitubercular Drugs, Antifungal Drugs, Peptides, and Metronidazole.$g29.$tAntiviral, Antimalarial, and Anthelmintic Drugs.$g30.$tDrugs for Urinary Tract Disorders --$gUnit VI.$tImmunologic Agents.$g31.$tHIV- and AIDS-Related Agents /$rPatricia S. Lincoln and Robert Kizior.
505 80 $g32.$tVaccines /$rLynette M. Wachholz --$gUnit VII.$tAntineoplastic Agents.$g33.$tAnticancer Drugs.$g34.$tBiologic Response Modifiers /$rAnne E. Lara --$gUnit VIII.$tRespiratory Agents.$g35.$tDrugs for Common Upper Respiratory Infections.$g36.$tDrugs for Acute and Chronic Lower Respiratory Disorders --$gUnit IX.$tCardiovascular Agents.$g37.$tDrugs for Cardiac Disorders.$g38.$tDiuretics.$g39.$tAntihypertensive Drugs.$g40.$tDrugs for Circulatory Disorders --$gUnit X.$tGastrointestinal Agents.$g41.$tDrugs for Gastrointestinal Tract Disorders.$g42.$tAntiulcer Drugs --$gUnit XI.$tEye, Ear, and Skin Agents.$g43.$tDrugs for Disorders of the Eye and the Ear.$g44.$tDrugs for Dermatologic Disorders --$gUnit XII.$tEndocrine Agents.$g45.$tEndocrine Pharmacology: Pituitary, Thyroid, Parathyroids, and Adrenals.$g46.$tAntidiabetic Drugs --$gUnit XIII.$tReproductive and Gender-Related Agents.
505 80 $g47.$tDrugs Associated with the Female Reproductive Cycle: Pregnancy, Preterm Neonate, Labor, and Delivery /$rJane Purnell Taylor and Linda Goodwin.$g48.$tDrugs Associated with the Postpartum and the Newborn /$rJane Purnell Taylor and Linda Goodwin.$g49.$tDrugs Related to Women's Health and Disorders /$rJane Purnell Taylor and Linda Goodwin.$g50.$tDrugs Related to Reproductive Health: Male Reproductive Disorders /$rNancy C. Sharts-Hopko and Kathleen J. Jones.$g51.$tDrugs Related to Reproductive Health: Infertility and Sexually Transmitted Diseases /$rNancy C. Sharts-Hopko and Kathleen J. Jones --$gUnit XIV.$tEmergency Agents.$g52.$tAdult and Pediatric Emergency Drugs /$rLinda Laskowski-Jones --$gApp. A.$tGeneric Drugs With Corresponding Canadian Trade Drug Names --$gApp. B.$tRecommended Daily Allowances for Vitamins and Minerals During Pregnancy --$gApp. C.$tLaboratory Tests Related to Drug Use.
650 0 $aPharmacology.$0http://id.loc.gov/authorities/subjects/sh85100599
650 0 $aNursing.$0http://id.loc.gov/authorities/subjects/sh85093362
650 12 $aPharmacology.$0https://id.nlm.nih.gov/mesh/D010600
650 22 $aDrug Therapy.$0https://id.nlm.nih.gov/mesh/D004358
655 2 $aNurses Instruction.$0https://id.nlm.nih.gov/mesh/D020488
700 1 $aHayes, Evelyn R.$0http://id.loc.gov/authorities/names/n85342881
852 00 $boff,hsl$hRM301$i.K44 2000